ClinicalTrialsFinder

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor Clinical Trials in Leuven

1 recruitingLeuven, Belgium

Showing 1–1 of 1 trials

Recruiting

LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Universitaire Ziekenhuizen KU Leuven39 enrolled1 locationNCT04216121